IsoniazidAntitubercular AgentsRifampinMycobacterium tuberculosisLiver DiseasesPyrazinamideEthambutolLiverAntibiotics, AntitubercularLiver TransplantationLiver NeoplasmsTuberculosis, Multidrug-ResistantTuberculosisTuberculosis, PulmonaryLiver CirrhosisMicrosomes, LiverEthionamideLiver RegenerationFatty LiverDrug-Induced Liver InjuryStreptomycinAminosalicylic AcidsMicrobial Sensitivity TestsDrug Therapy, CombinationLiver Function TestsAminosalicylic AcidMitochondria, LiverDrug Resistance, BacterialTreatment OutcomeCatalaseIsonicotinic AcidsDrug Administration ScheduleTime FactorsLiver ExtractsLiver Neoplasms, ExperimentalLiver CirculationThioacetazoneMycobacteriumMycolic AcidsLiver Failure, AcuteDrug Resistance, Multiple, BacterialLiver AbscessAza CompoundsLatent TuberculosisDrug Resistance, MicrobialLiver Diseases, AlcoholicOxidoreductasesBacterial ProteinsMycobacteriophagesSputumClofazimineRifamycinsColony Count, MicrobialHepatectomyAntineoplastic Combined Chemotherapy ProtocolsTuberculin TestHepatocytesArylamine N-AcetyltransferaseHydrazinesQuinolinesMycobacterium smegmatisHIV InfectionsAlanine TransaminaseDose-Response Relationship, DrugLiver Cirrhosis, ExperimentalDirectly Observed TherapyRetrospective StudiesLiver Cirrhosis, AlcoholicDiarylquinolinesCytochrome P-450 CYP2E1Tuberculosis, MeningealRifabutinAdministration, OralLiver, ArtificialLiver Glycogen